Re: Intermittent Fasting Strategies and Their Effects on Body Weight and Other Cardiometabolic Risk Factors: Systematic Review and Network Meta-Analysis of Randomised Clinical Trials

Re: Intermittent Fasting Strategies and Their Effects on Body Weight and Other Cardiometabolic Risk Factors: Systematic Review and Network Meta-Analysis of Randomised Clinical Trials

BMJ (Latest)
BMJ (Latest)Apr 22, 2026

Why It Matters

The debate shapes dietary guidelines and insurance‑covered weight‑loss programs; premature claims could mislead clinicians and patients about the best sustainable strategy.

Key Takeaways

  • CER studies vary widely in calorie deficit and diet composition.
  • Short‑term fasting benefits may not persist with long‑term adherence.
  • Prior meta‑analyses show modest weight loss differences between IF and CER.
  • Clinical superiority of alternate‑day fasting remains unproven.
  • Large, standardized RCTs are needed to confirm comparative effectiveness.

Pulse Analysis

Intermittent fasting (IF) has surged in popularity, buoyed by studies that tout rapid weight loss and improved insulin sensitivity. The latest network meta‑analysis compared alternate‑day fasting with continuous energy restriction (CER), concluding that IF may confer superior metabolic benefits. Such findings attract media attention and influence diet‑centric health policies, prompting clinicians to consider IF as a first‑line recommendation for obesity and cardiometabolic risk management.

However, the critique raised by Dr. Ahmad highlights key methodological gaps. The CER interventions pooled in the analysis differ markedly in prescribed calorie deficits, macronutrient ratios, and participant adherence, creating an uneven playing field. Moreover, many IF trials report short‑term outcomes; adherence wanes over months, and long‑term sustainability remains uncertain. Existing literature, including earlier meta‑analyses, often shows only modest, statistically insignificant differences in weight loss and blood‑pressure reductions between IF and CER, suggesting that the purported superiority may be overstated.

For practitioners and policymakers, the takeaway is clear: dietary recommendations should be grounded in robust, head‑to‑head trials that standardize protocols and track long‑term adherence. Until large-scale, multi‑year randomized controlled studies directly compare IF and CER under uniform conditions, clinicians should present both options as viable, emphasizing individual preference, lifestyle fit, and realistic sustainability. This balanced approach mitigates the risk of overpromising benefits and supports evidence‑based nutrition counseling.

Re: Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials

Comments

Want to join the conversation?

Loading comments...